B2B2C for Biotech
Struggling to keep pace with the market growth in Biotech?
Your market opportunity is growing rapidly. By 2023, bioprocessing, stainless steel, single-use, and medical equipment sub-sectors are each expected to be sized in the tens of billions of dollars. To compete, you need to reduce the time and effort required to get your products to those companies that are making a real impact on patient outcomes.
The challenge
You’ve hit a customer acquisition wall, and you’re ready to try something a little bit different
You want to acquire a large volume of customers at a remarkably low per-customer acquisition cost. Who doesn’t?
You’re wholesaling your supplies through several resellers in a traditional channel partnership setup. Still, you want to communicate with your customers more directly and promote your brand without necessarily going direct-to-consumer.
The solution
Tap into your distributors’ business to acquire a large volume of customers and sell more units
With B2B2C, you can directly access end customers through a second business, interacting with them under your own brand. Arm your distributors, resellers, and partners with your product configurator so that clinics can configure your systems to their exact requirements and make an instant purchase.
With B2B2C, you can acquire a large volume of customers in bulk, achieve economies of scale and gain a level of credibility by partnering with other respected brands.
Featured Resource
Sales & Engineering Automation with CPQ: A Biotech Industry Guide
Learn how Biotech Single-Use and Processing companies are reducing their sales cycles to meet increased demand for their products.
Sales and engineering automation through the use of CAD drawings gives you this ability, providing sales reps with the visual outputs they need to win deals, without having to rely on an over-stretched engineering department that should be focussed on innovation rather than transactional sales tasks.